FAD SINCRONA:
COME IL DERMATOLOGOPUO’ CONTRIBUIRE ALLOSCREENING
DELCANCRO PANCREATICOEREDITARIO

13 October 2026
WEBINAR

TYPOLOGY

FAD SINGLE

FREE

DATE

13/10/2026

END DATE

13/10/2026
Sign in to join the course

Scientific rationale

Hereditary pancreatic carcinoma is a condition with a high clinical impact, in which early identification of risky subjects is essential for the activation of adequate surveillance programs. Certain dermatological diseases and genetic syndromes, such as Melanoma-Nevo Displasmic syndrome and Peutz-Jeghers syndrome, can be important indicators of predisposition to pancreas tumor.

The webinar aims to deepen the role of the dermatologist in the identification of patients candidates for screening, presenting the latest evidence and experiences of national reference centers. The meeting will promote multidisciplinary comparison of early diagnosis strategies and taking charge of high-risk subjects, with the aim of improving welfare paths and clinical outcomes.

WITH THE PATROCINIUS OF

START
13 October 2026
END OF COURSE
13 October 2026
TYPOLOGY
FAD SINGLE
PARTICIPANTS
100
TARGETS
ALL HEALTH PROFESSIONALS
ECM ID
E.C.M.
REGISTERING QUOTA
Free
E-MAIL
info@studio-congressi.com
Studio Congressi s.r.l.
VAT: 01975530187
Reg. Companies of Pv: 01975530187
R.E.A.: 235792
Social Capital: € 260.000,00

Studio Congressi s.r.l. and Med Tech Science s.r.l.
Avenue of Liberty, 17 | 27100 Pavia (PV)
📞 +39.0382.21424 | +39.351.8055151
info@studio-congressi.com
medtechscience2@gmail.com
Code Recipient SDI BA6ET11

Med Tech Science Ltd.
VAT No: 02080160183
Reg. Pv: 02080160183
R.E.A.: 244029
Social Capital: € 100,000,00

Studio Congressi s.r.l. and Med Tech Science s.r.l.
Avenue of Liberty, 17 | 27100 Pavia (PV)
📞 +39.0382.21424 | +39.351.8055151
info@studio-congressi.com
medtechscience2@gmail.com
Code Recipient SDI BA6ET11

Studio Congressi s.r.l.
VAT: 01975530187
Reg. Companies of Pv: 01975530187
R.E.A.: 235792
Social Capital: € 260.000,00

Med Tech Science Ltd.
VAT No: 02080160183
Reg. Pv: 02080160183
R.E.A.: 244029
Social Capital: € 100,000,00